Oral Vitamin D supplementation with 800IU versus 400IU in improving serum Vitamin D levels among term breastfed Small for Gestational Age neonates
Phase 1
- Conditions
- Health Condition 1: P051- Newborn small for gestational age
- Registration Number
- CTRI/2023/09/057291
- Lead Sponsor
- ABVIMS & DR RML HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Term gestation and exclusively breastfed Small for Gestational Age neonates
Exclusion Criteria
Presence of lethal congenital malformations/chromosomal abnormalities, Need for NICU admission > 7 days, Mothers on anticonvulsant or antitubercular drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum 25 hydroxy Vitamin D levelsTimepoint: 14 weeks postnatal age
- Secondary Outcome Measures
Name Time Method Clinical ricketsTimepoint: 14 weeks postnatal age;HypercalcemiaTimepoint: 14 weeks postnatal age;HyperparathyroidismTimepoint: 14 weeks postnatal age;RehospitalisationTimepoint: 14 weeks postnatal age;Respiratory morbiditiesTimepoint: 14 weeks postnatal age;Severe Vitamin D deficiencyTimepoint: 14 weeks postnatal age;Vitamin D deficiencyTimepoint: 14 weeks postnatal age;Vitamin D insufficiencyTimepoint: 14 weeks postnatal age;Vitamin D toxicityTimepoint: 14 weeks postnatal age